6
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Acute Administration of Individual Optimal Dose of Physostigmine Fails to Improve Mnesic Performances in Alzheimers Presenile Dementia

, , &
Pages 143-147 | Received 02 Aug 1982, Published online: 07 Jul 2009

References

  • Alderdice M. T. Physostigmine, but not neostigmine, inhibits acetylcholine release. Brain Research 1979; 178: 596–599
  • Bartus R. T. Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine. Pharmacology, Biochemistry and Behaviour 1978; 9: 833–836
  • Bartus R. T. Physostigmine and recent memory: effects in young and aged nonhuman primates. Science 1979; 206: 1087–1089
  • Caltagirone C., Gainotti G., Masullo C. Oral administration of chronic physostigmine does not improve cognitive and mnesic performances of Alzheimer's Presenile Dementia. The International Journal of Neuroscience 1982; 16: 247–249
  • Corkin S. Acetylcholine, aging and Alzheimer's disease. Implications for treatment. Trends in Neurosciences 1981; 4(12)287–290
  • Davies P., Maloney A. J. F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2: 1403
  • Davis K. L., Mohs R. C., Tinklenberg J. R., Pfefferbaum A., Hollister L. E., Koppell B. S. Physostigmine: improvement of long term memory processes in normal humans. Science 1978; 201: 272–274
  • Drachman D. A., Sahakian B. J. Memory and cognitive function in the Elderly. A Preliminary trial of physostigmine. Archives of Neurology 1980; 37: 674–675
  • Glen A. I. M., Whalley L. J. Alzheimer's disease. Early recognition of potentially reversible deficits. Churchill Livingstone, Edinburgh 1979
  • Gottfries C. G., Gottfries I., Roos B. E. The investigation of homovanillic acid in the human brain and its correlation to senile dementia. British Journal of Psychiatry 1969a; 115: 563–574
  • Gottfries C. G., Gottfries I., Roos B. E. Homovanillic acid and 5-hydroxyindolacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism. Journal of Neurochemistry 1969b; 16: 1341–1345
  • Mann D. M. A., Yates P. O., Hawkes J. The noradrenergic system in Alzheimer and multiinfarct dementias. Journal of Neurology, Neurosurgery and Psychiatry 1982; 45: 113–119
  • Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977; 1: 189
  • Rappaport F., Fischl J., Pinto N. An improved method for the estimation of cholinesterase activity in serum. Clinica Chimica Acta 1959; 4: 227–230
  • Zeisel S. H., Reinstein D. K., Wurtman R. J., Corkin S., Grawdon J. H. Memory disorders associated with aging. Trends in Neurosciences 1981; 4(11)VIII–IX

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.